Virulence Factor Made by Influenza Virus is Potential Target for Vaccine Drug Development
A new study describes how NS1, a protein produced by influenza A viruses, suppresses the body's immune responses to viral infection. Researchers present the potential to develop a live attenuated vaccine based on an engineered influenza A virus lacking NS1 and to design antiviral drugs that target NS1. The study is published in Journal of Interferon & Cytokine Research (JICR) from Mary Ann Liebert, Inc., publishers.
In the article, "Interactions Between NS1 of Influenza A Viruses and Interferon-a/ß: Determinants for Vaccine Development," coauthors Ben Wang and Eleanor Fish, University Health Network and University of Toronto, Canada, examine the body's first line of defense against infectious agents such as viruses--the interferon (IFN)-a/ß response. The researchers describe the effects of IFN-a/ß on influenza A virus replication, how NS-1 inhibits IFN-a/ß production, and the potential for using IFN-a/ß or blocking NS-1 activity as a treatment for influenza A virus infection.
"Influenza viruses remain a major cause of human morbidity and mortality. This article suggests potential new approaches to combat these viruses," says Journal of Interferon & Cytokine Research Co-Editor-in-Chief Ganes C. Sen, Department of Immunology, Cleveland Clinic Foundation, Cleveland.
Source: Mary Ann Liebert, Inc.
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.
